ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 44 filers reported holding ARGOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $845,000 | -1.4% | 172,505 | 0.0% | 0.03% | 0.0% |
| Q3 2016 | $857,000 | -18.9% | 172,505 | 0.0% | 0.03% | +3.3% |
| Q2 2016 | $1,057,000 | -4.3% | 172,505 | 0.0% | 0.03% | -3.2% |
| Q1 2016 | $1,104,000 | +124.8% | 172,505 | -18.8% | 0.03% | +138.5% |
| Q4 2015 | $491,000 | -52.1% | 212,505 | 0.0% | 0.01% | -45.8% |
| Q3 2015 | $1,024,000 | -29.7% | 212,505 | 0.0% | 0.02% | -20.0% |
| Q2 2015 | $1,456,000 | -25.4% | 212,505 | -3.0% | 0.03% | -28.6% |
| Q1 2015 | $1,952,000 | -17.5% | 219,055 | -7.4% | 0.04% | -14.3% |
| Q4 2014 | $2,366,000 | -5.9% | 236,550 | -5.4% | 0.05% | +2.1% |
| Q3 2014 | $2,515,000 | +25.2% | 250,000 | 0.0% | 0.05% | +37.1% |
| Q2 2014 | $2,008,000 | -19.7% | 250,000 | 0.0% | 0.04% | -18.6% |
| Q1 2014 | $2,500,000 | – | 250,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $5,984,000 | 15.97% |
| Pharmstandard International S.A. | 5,120,604 | $2,314,000 | 6.17% |
| SANDERS MORRIS HARRIS LLC | 290,424 | $132,000 | 0.02% |
| WEDBUSH SECURITIES INC | 63,500 | $29,000 | 0.00% |
| Virtu KCG Holdings LLC | 127,073 | $57,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $90,000 | 0.00% |
| WASATCH ADVISORS LP | 186,900 | $85,000 | 0.00% |
| STATE STREET CORP | 184,194 | $82,000 | 0.00% |
| SG Americas Securities, LLC | 17,652 | $8,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 398 | $0 | 0.00% |